Contributors

  • ORCID

Wilkinson-Berka, Jennifer

NLA Persistent Identifier
http://nla.gov.au/nla.party-1623627

Related people and organisations

Resources for Jennifer Wilkinson-Berka

Selected resources (187)

ORCID

  1. Researcher Profile at ORCID
    http://orcid.org/0000-0003-3512-4030
  2. Mesenchymal stem cells deliver exogenous microRNA-let7c exosomes to attenuate renal fibrosis
    [2016-08]
  3. Are reactive oxygen species still the basis for diabetic complications?
    [2016]
  4. Inhibition of the Nuclear Receptor RORγ and Interleukin-17A Suppresses Neovascular Retinopathy: Involvement of Immunocompetent Microglia
    [2016]
  5. Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an M1 phenotype in retinal microglia
    [2016]
  6. Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an m1 phenotype in retinal microglia
    [2015-02]
  7. VEGF-D promotes pulmonary oedema in hyperoxic acute lung injury
    [2016]
  8. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers
    [2015]
  9. Ebselen by modulating oxidative stress improves hypoxia-induced macroglial müller cell and vascular injury in the retina
    [2015]
  10. FT011, a novel cardiorenal protective drug, reduces inflammation, gliosis and vascular injury in rats with diabetic retinopathy
    [2015]
  11. Inhibition of NOX1/4 with GKT137831: A potential novel treatment to attenuate neuroglial cell inflammation in the retina
    [2015]
  12. Retinal Vasculopathy Is Reduced by Dietary Salt Restriction: Involvement of Glia, ENaC , and the Renin-Angiotensin-Aldosterone System
    [2014-07]
  13. NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy
    [2014-06]
  14. NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy
    [2014]
  15. The Vasoneuronal Effects of AT1 Receptor Blockade in a Rat Model of Retinopathy of Prematurity
    [2014-06]
  16. The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity
    [2014]
  17. Retinal vasculopathy is reduced by dietary salt restriction: Involvement of glia, ENaCα, and the renin-angiotensin-aldosterone system
    [2014]
  18. The Renin-Angiotensin System and Advanced Glycation End-Products in Diabetic Retinopathy: Impacts and Synergies.
    [2013-08]
  19. Brain and retinal microglia in health and disease: An unrecognized target of the renin-angiotensin system
    [2013-07]
  20. Brain and retinal microglia in health and disease: An unrecognized target of the renin-angiotensin system
    [2013]
  21. Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy
    [2013-02]
  22. Lack of the Antioxidant Glutathione Peroxidase-1 (GPx1) Exacerbates Retinopathy of Prematurity in Mice
    [2013-01]
  23. Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in Mice
    [2013]
  24. Reactive oxygen species, Nox and angiotensin II in angiogenesis: Implications for retinopathy
    [2013]
  25. The renin-angiotensin system and advanced glycation end-products in diabetic retinopathy: impacts and synergies.
    [2013]
  26. The retinal renin–angiotensin system: Roles of angiotensin II and aldosterone
    [2012-07]
  27. The retinal renin-angiotensin system: Roles of angiotensin II and aldosterone
    [2012]
  28. Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies
    [2012-06]
  29. Oxidative stress, nox isoforms and complications of diabetes-potential targets for novel therapies
    [2012]
  30. Neovascularization Is Attenuated With Aldosterone Synthase Inhibition in Rats With Retinopathy
    [2012-01]
  31. 1030 ACTIVATION OF RETINAL MICROGLIA IS ATTENUATED WITH ANGIOTENSIN II AND ALDOSTERONE BLOCKADE
    [2012]
  32. Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy
    [2012]
  33. Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat
    [2011-07]
  34. Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat
    [2011]
  35. Prorenin and the (pro)renin receptor: recent advances and implications for retinal development and disease
    [2011-01]
  36. Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy
    [2011]
  37. Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy
    [2010]
  38. Prorenin and the (pro)renin receptor: Recent advances and implications for retinal development and disease
    [2011]
  39. Candesartan Attenuates Diabetic Retinal Vascular Pathology by Restoring Glyoxalase-I Function
    [2010-09]
  40. Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function
    [2010]
  41. RILLKKMPSV Influences the Vasculature, Neurons and Glia, and (Pro)Renin Receptor Expression in the Retina
    [2010-04]
  42. Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity
    [2010-01]
  43. Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity
    [2010]
  44. Prorenin and the (pro)renin receptor: Do they have a pathogenic role in the retina?
    [2010]
  45. RILLKKMPSV Influences the vasculature, neurons and glia, and (Pro)renin receptor expression in the Retina
    [2010]
  46. The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature
    [2010]
  47. The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy.
    [2010]
  48. The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy
    [2009-09]
  49. Prorenin and the (Pro)renin Receptor in Retinal Pathology
    [2009-08]
  50. Prorenin and the (pro)renin receptor in retinal pathology
    [2009]
  51. (Pro)renin Receptor: A Treatment Target for Diabetic Retinopathy?
    [2009-06]
  52. (Pro)renin receptor: A treatment target for diabetic retinopathy?
    [2009]
  53. Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina
    [2009-06]
  54. Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina
    [2009]
  55. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology
    [2009]
  56. Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology
    [2008-11]
  57. Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats
    [2008-01]
  58. Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats
    [2008]
  59. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy
    [2008]
  60. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy
    [2008]
  61. Prorenin and the (Pro)renin Receptor in Ocular Pathology
    [2008]
  62. Prorenin and the (pro)renin receptor in ocular pathology
    [2008]
  63. Update on the Treatment of Diabetic Retinopathy
    [2008]
  64. Update on the treatment of diabetic retinopathy
    [2008]
  65. Editorial [Hot Topic: Pathogenesis and Treatment of Diabetic Complications,Retinopathy, Nephropathy and Cardiomyopathy (Executive Editor: J.L. Wilkinson-Berka)]
    [2007-09]
  66. Editorial: Pathogenesis and treatment of diabetic complications, retinopathy, nephropathy and cardiomyopathy
    [2007]
  67. Neuronal and Glial Cell Abnormality as Predictors of Progression of Diabetic Retinopathy
    [2007-09]
  68. Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy
    [2007]
  69. Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity
    [2007-07]
  70. Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity
    [2007]
  71. Retinal Dysfunction in Diabetic Ren-2 Rats Is Ameliorated by Treatment with Valsartan but Not Atenolol
    [2007-02]
  72. Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol
    [2007]
  73. Progressive diabetic nephropathy in the Ren-2 rat
    [2007-01]
  74. Progressive diabetic nephropathy in the Ren-2 rat [1]
    [2007]
  75. An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy
    [2007]
  76. Valsartan but not Atenolol Improves Vascular Pathology in Diabetic Ren-2 Rat Retina
    [2007]
  77. The Role of Growth Hormone, Insulin-Like Growth Factor and Somatostatin in Diabetic Retinopathy
    [2006-11]
  78. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy
    [2006]
  79. Angiotensin and diabetic retinopathy
    [2006-05]
  80. Angiotensin and diabetic retinopathy
    [2006]
  81. SB-267268, a Nonpeptidic Antagonist of  v 3 and  v 5 Integrins, Reduces Angiogenesis and VEGF Expression in a Mouse Model of Retinopathy of Prematurity
    [2006-04]
  82. SB-267268, a nonpeptidic antagonist of αvβ 3 and αvβ5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity
    [2006]
  83. Renin Inhibition: New Potential for an Old Therapeutic Target
    [2005-08]
  84. Sandford Lloyd Skinner (1933-2005)
    [2005-08]
  85. Dysfunction of retinal neurons and glia during diabetes
    [2005-05]
  86. Dysfunction of retinal neurons and glia during diabetes
    [2005]
  87. Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye
    [2005]
  88. Renin inhibition: New potential for an old therapeutic target
    [2005]
  89. The renin-angiotensin system and the developing retinal vasculature
    [2005]
  90. Tranilast attenuates cardiac matrix deposition in experimental diabetes: Role of transforming growth factor-β
    [2005]
  91. Angiotensin and Bradykinin: Targets for the Treatment of Vascular and Neuro-Glial Pathology in Diabetic Retinopathy
    [2004-10]
  92. Angiotensin and bradykinin: Targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy
    [2004]
  93. Preface [HotTopic: Cytokine Therapies for Diabetic Microvascular Complications (Executive Editor: J.L. Wilkinson-Berka)]
    [2004-10]
  94. Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide
    [2004-10]
  95. Vasoactive factors and diabetic retinopathy: Vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide
    [2004]
  96. Diabetes and retinal vascular disorders: role of the renin–angiotensin system
    [2004-07]
  97. THE RENIN-ANGIOTENSIN SYSTEM (RAS) IN THE DEVELOPING RETINA OF SPRAGUE DAWLEY AND TRANSGENIC (MREN-2)27 RATS: EFFECT OF RAS BLOCKADE
    [2004-05]
  98. Inhibition of Platelet-Derived Growth Factor Promotes Pericyte Loss and Angiogenesis in Ischemic Retinopathy
    [2004-04]
  99. Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: Attenuation with renin-angiotensin blockade
    [2004-02]
  100. Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: Attenuation with renin-angiotensin blockade
    [2004]
  101. Cardiorenal Protective Effects of Vasopeptidase Inhibition with Omapatrilat in Hypertensive Transgenic (mREN‐2)27 Rats
    [2004-01]
  102. Angiotensin II influences ovarian follicle development in the transgenic (mRen-2)27 and Sprague-Dawley rat
    [2004]
  103. Diabetes and retinal vascular disorders: Role of the renin-angiotensin system
    [2004]
  104. Inhibition of Platelet-Derived Growth Factor Promotes Pericyte Loss and Angiogenesis in Ischemic Retinopathy
    [2004]
  105. Preface
    [2004]
  106. Retinal Angiogenesis Is Mediated by an Interaction between the Angiotensin Type 2 Receptor, VEGF, and Angiopoietin
    [2003-09]
  107. The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations
    [2003-08]
  108. The renin-angiotensin system and the long-term complications of diabetes: Pathophysiological and therapeutic considerations
    [2003]
  109. Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2)27 rat: effect of angiotensin-converting enzyme inhibition
    [2003-06]
  110. COX-2 Inhibition and Retinal Angiogenesis in a Mouse Model of Retinopathy of Prematurity
    [2003-03]
  111. COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity
    [2003]
  112. Protein Kinase C   Inhibition Attenuates the Progression of Experimental Diabetic Nephropathy in the Presence of Continued Hypertension
    [2003-02]
  113. Protein kinase C β inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension
    [2003]
  114. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
    [2003]
  115. Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2)27 rat: Effect of angiotensin-converting enzyme inhibition
    [2003]
  116. Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin
    [2003]
  117. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: Transgenic and interventional studies
    [2003]
  118. ALT-946 and Aminoguanidine, Inhibitors of Advanced Glycation, Improve Severe Nephropathy in the Diabetic Transgenic (mREN-2)27 Rat
    [2002-11]
  119. OMAPATRILAT IMPROVES CARDIORENAL PATHOLOGY IN THE HYPERTENSIVE m(REN-2)27 RAT
    [2002-02]
  120. OSTEOPONTIN-INDUCED MACROPHAGE RECRUITMENT IN ADVANCED EXPERIMENTAL DIABETIC NEPHROPATHY
    [2002-02]
  121. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats
    [2002-01]
  122. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats
    [2002]
  123. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat
    [2002]
  124. Characterisation of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat
    [2002]
  125. Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats
    [2002]
  126. Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats
    [2002]
  127. Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade
    [2001-07]
  128. Podocyte foot process broadening in experimental diabetic nephropathy: Amelioration with renin-angiotensin blockade
    [2001]
  129. Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats
    [2001-02]
  130. Angiotensin and Renal Fibrosis
    [2001]
  131. Angiotensin and renal fibrosis
    [2001]
  132. Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats
    [2001]
  133. Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat
    [2001]
  134. The Interaction between the Renin-Angiotensin System and Vascular Endothelial Growth Factor in the Pathogenesis of Retinal Neovascularization in Diabetes
    [2001]
  135. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes
    [2001]
  136. AMINOGUANIDINE PREVENTS SEVERE GLOMERULOSCLEROSIS BUT NOT TUBULOINTERSTITIAL INJURY IN THE DIABETIC TRANSGENIC REN-2 RAT
    [2000-10]
  137. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes
    [2000-10]
  138. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes
    [2000]
  139. Protective role for Epidermal Growth Factor in Advanced Diabetic Nephropathy of Transgenic (mRen-2)27 rats
    [2000-10]
  140. Protective role for Epidermal Growth Factor in Advanced Diabetic Nephropathy of Transgenic (mRen-2)27 rats
    [2000-10]
  141. First Report Of Active Renin In Rat Amniotic Fluid
    [2000-08]
  142. First report of active renin in rat amniotic fluid
    [2000]
  143. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat
    [2000-05]
  144. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat
    [2000]
  145. Retinal neovascularization is prevented by blockade of the renin-angiotensin system
    [2000]
  146. Pathological Expression of Renin and Angiotensin II in the Renal Tubule after Subtotal Nephrectomy
    [1999-08]
  147. Increased bradykinin and “normal” angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats
    [1999-07]
  148. Increased bradykinin and 'normal' angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats
    [1999]
  149. Localization of Secreted Protein Acidic and Rich in Cysteine (SPARC) Expression in the Rat Eye
    [1999-01]
  150. Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye
    [1999]
  151. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy: Implications for the pathogenesis of tubulointerstitial fibrosis
    [1999]
  152. Potassium control of extrarenal renin secretion in transgenic (mRen-2)27 and normal rats
    [1999]
  153. Renin in thymus, gut, hindlimb, and adrenal of (mRen-2)27 and normal rats: Secretion and content studies
    [1999]
  154. Renal expression of transforming growth factor-beta inducible gene-h3 (betaig-h3) in normal and diabetic rats1
    [1998-10]
  155. Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats
    [1998]
  156. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)
    [1998-08]
  157. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)
    [1998]
  158. Distinct localization of renin and GLUT-4 in juxtaglomerular cells of mouse kidney
    [1998]
  159. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes
    [1998]
  160. Localization studies of IGFBP-2 and IGFBP-5 in the anterior compartment of the eye
    [1997-01]
  161. Localization studies of IGFBP-2 and IGFBP-5 in the anterior compartment of the eye
    [1997]
  162. Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney
    [1997]
  163. Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney
    [1997]
  164. Cell-specific regulation of mRNAs for IGF-I and IGF-binding proteins-4 and -5 in streptozotocin-diabetic rat kidney
    [1997]
  165. Diabetic renal failure and associated pathology are ameliorated by Perindopril treatment in transgenic Ren-2 rats
    [1997]
  166. Diabetic renal failure and associated pathology are ameliorated by perindopril treatment in transgenic Ren-2 rats
    [1997]
  167. Light-microscopic immunolocalization of fibroblast growth factor-1 and -2 in adult rat kidney
    [1996-07]
  168. Light-microscopic immunolocalization of fibroblast growth factor-1 and -2 in adult rat kidney
    [1996]
  169. Adrenaline cells of the rat adrenal cortex and medulla contain renin and prorenin
    [1996-05]
  170. Adrenaline cells of the rat adrenal cortex and medulla contain renin and prorenin
    [1996]
  171. Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye
    [1996]
  172. Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney
    [1995-08]
  173. Differential distribution of mRNA for the α- and β-subunits of chorionic gonadotrophin in the implantation stage blastocyst of the marmoset monkey
    [1995]
  174. Erratum: Differential distribution of mRNA for the α- and β-subunits of chorionic gonadotrophin in the implantation stage blastocyst of the marmoset monkey (Placenta (1995) 16 (335-346))
    [1995]
  175. Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney
    [1995]
  176. Luteinizing hormone/chorionic gonadotropin bioactivity in the common marmoset (Callithrix jacchus) is due to a chorionic gonadotropin molecule with a structure intermediate between human chorionic gonadotropin and human luteinizing hormone
    [1995]
  177. Renin-containing muller cells of the retina display endocrine features
    [1995]
  178. Reflective interconnection networks
    [1994-07]
  179. Effects of angiotensin converting enzyme inhibition on glomerular number, juxtaglomerular cell activity and renin content in experimental unilateral hydronephrosis
    [1994]
  180. Renin processing and secretion in adrenal and retina of transgenic (mREN-2)27 rats
    [1994]
  181. Renin processing and secretion in adrenal and retina of transgenic (mREN-2)27 rats
    [1994]
  182. Renin processing in cultured juxtaglomerular cells of the hydronephrotic mouse kidney
    [1993]
  183. Renin processing studied by immunogold localization of prorenin and renin in granular juxtaglomerular cells in mice treated with enalapril
    [1992-04]
  184. Renin processing studied by immunogold localization of prorenin and renin in granular juxtaglomerular cells in mice treated with enalapril
    [1992]
  185. Production of rat renin fusion protein in Escherichia coli and the preparation of renin-specific antisera
    [1990-10]
  186. Granular juxtaglomerular cells and prorenin synthesis in mice treated with enalapril
    [1990]
  187. Production of rat renin fusion protein in Escherichia coli and the preparation of renin-specific antisera
    [1990]

Resources by Jennifer Wilkinson-Berka (166)

  1. Prorenin and the (pro)renin receptor in ocular pathology
    Wilkinson-Berka, Jennifer
    [ Article : 2008 ]
    Possibly online
    At Monash Uni Repos
    This resource is very relevant to your query (score: 5.443)

    This resource is very relevant to your query (score: 5.443)

  2. Angiotensin and diabetic retinopathy
    Wilkinson-Berka, Jennifer
    [ Article : 2006 ]
    Possibly online
    At Monash Uni Repos
    This resource is very relevant to your query (score: 5.433)

    This resource is very relevant to your query (score: 5.433)

  3. Vasoactive factors and diabetic retinopathy: Vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide
    Wilkinson-Berka, Jennifer
    [ Article : 2004 ]
    Possibly online
    At Monash Uni Repos
    This resource is very relevant to your query (score: 5.43)

    This resource is very relevant to your query (score: 5.43)

  4. Diabetes and retinal vascular disorders: role of the renin-angiotensin system
    Wilkinson-Berka, Jennifer
    [ Article : 2004 ]
    Possibly online
    At Monash Uni Repos
    This resource is very relevant to your query (score: 5.393)

    This resource is very relevant to your query (score: 5.393)

  5. Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.(Research)(Report)
    Deliyanti, Devy; Wilkinson-Berka, Jennifer L
    Journal of Neuroinflammation
    [ Article : 2015 ]
    View online (conditions apply)
    This resource is very relevant to your query (score: 3.702)

    This resource is very relevant to your query (score: 3.702)

  6. The renin-angiotensin system and the developing retinal vasculature
    Sarlos, Stella; Wilkinson-Berka, Jennifer
    [ Article : 2005 ]
    Possibly online
    At Monash Uni Repos
    This resource is very relevant to your query (score: 3.702)

    This resource is very relevant to your query (score: 3.702)

  7. (Pro)renin receptor: a treatment target for diabetic retmopathy.(COMMENTARY)(Report)
    Wilkinson-Berka, Jennifer L; Campbell, Duncan J
    Diabetes
    [ Article : 2009 ]
    View online (conditions apply)
    This resource is very relevant to your query (score: 3.688)

    This resource is very relevant to your query (score: 3.688)

  8. Update on the treatment of diabetic retinopathy
    Wilkinson-Berka, Jennifer; Miller, Antonia
    [ Article : 2008 ]
    Possibly online
    At Monash Uni Repos
    This resource is very relevant to your query (score: 3.654)

    This resource is very relevant to your query (score: 3.654)

  9. Prorenin and the (pro)renin receptor: recent advances and implications for retinal development and disease
    Wilkinson-Berka, Jennifer; Miller, Antonia; Binger, Katrina
    [ Article : 2011 ]
    Possibly online
    At Monash Uni Repos
    This resource is very relevant to your query (score: 3.202)

    This resource is very relevant to your query (score: 3.202)

  10. The retinal renin-angiotensin system: roles of angiotensin II and aldosterone
    Wilkinson-Berka, Jennifer; Agrotis, Alexander; Deliyanti, Devy
    [ Article : 2012 ]
    Possibly online
    At Monash Uni Repos
    This resource is very relevant to your query (score: 3.199)

    This resource is very relevant to your query (score: 3.199)

More...

No user comments for this person

Add a comment


Show comments and reviews from Amazon users

Possibly related

Digitised newspapers and more

Searching...

Minimise

Diaries, letters, archives

Searching...

Minimise

Archived websites (1996 – now)

Searching...

Minimise

Pictures, photos, objects

Searching...

Minimise

Books

Searching...

Minimise

Music, sound and video

Searching...

Minimise

People and organisations

Searching...

Minimise

Journals, articles and data sets

Searching...

Minimise

Maps

Searching...

Minimise

Lists

Searching...

Minimise

Government Gazettes

Searching...

Minimise

Diaries, letters, archives

No results

Minimise

Pictures, photos, objects

No results

Minimise

Music, sound and video

No results

Minimise

Maps

No results

Minimise

People and organisations

No results

Minimise

Digitised newspapers and more

No results

Minimise

Lists

No results

Minimise
  1. Effort required to finish shotgun-generated genome sequences differs significantly among vertebrates.(Research article)(Report)
    Blakesley, Robert W; Hansen, Nancy F; Gupta, Jyoti; McDowell, Jennifer C; Maskeri, Baishali; Barnabas, Beatrice B; Brooks, Shelise Y; Coleman, Holly; ...
    BMC Genomics
    [ Article : 2010 ]
    View online (conditions apply)
    This resource may be of limited relevance to your query (score: 0.015)

    This resource may be of limited relevance to your query (score: 0.015)

  2. Effect of systemic medications on onset and progression of diabetic retinopathy
    Silva, Paolo S; Cavallerano, Jerry D; Sun, Jennifer K; Aiello, Lloyd M; Aiello, Lloyd Paul
    Nature Reviews Endocrinology
    [ Article : 2010 ]
    View online (access conditions)
    This resource may be of limited relevance to your query (score: 0.013)

    This resource may be of limited relevance to your query (score: 0.013)

  3. The (pro)renin receptor mediates constitutive PLZF-independent pro-proliferative effects which are inhibited by bafilomycin but not genistein.(promyelocytic leukemia zinc finger protein)(Report)
    Kirsch, Sebastian; Schrezenmeier, Eva; Klare, Sabrina; Zaade, Daniela; Seidel, Kerstin; Schmitz, Jennifer; Bernhard, Sarah; Lauer, Dilyara; Slack, Mar...
    International Journal of Molecular Medicine
    [ Article : 2014 ]
    View online (conditions apply)
    This resource may be of limited relevance to your query (score: 0.012)

    This resource may be of limited relevance to your query (score: 0.012)

  4. Comparative genomics reveals high biological diversity and specific adaptations in the industrially and medically important fungal genus Aspergillus.(Report)
    de Vries, Ronald P; Riley, Robert; Wiebenga, Ad; Aguilar-Osorio, Guillermo; Amillis, Sotiris; Uchima, Cristiane Akemi; Anderluh, Gregor; Asadollahi, M...
    Genome Biology (Online Edition)
    [ Article : 2017 ]
    View online (conditions apply)
    This resource may only be vaguely related to your query: matching terms may only have been found in the full text contents of the resource (score: 0.003)

    This resource may only be vaguely related to your query: matching terms may only have been found in the full text contents of the resource (score: 0.003)

  1. Aldosterone and the mineralocorticoid receptor’s role in inflammation and vascular pathology in retinal disease
    Deliyanti, Devy
    [ Thesis : 2013 ]
    View online
    At Monash Uni Repos
    This resource is very relevant to your query (score: 2.235)

    This resource is very relevant to your query (score: 2.235)

  2. The role of renin angiotensin system in retinal inflammation
    Zhu, Tong
    [ Thesis : 2016 ]
    View online
    At Monash Uni Repos
    This resource is likely to be relevant to your query (score: 1.379)

    This resource is likely to be relevant to your query (score: 1.379)

  1. Website: ARC Centre of Excellence in Vision Science
    vision.edu.au
    Matching pages:
    • AOVSM - 29/7/2015
    • ... – Co-chairs: Gerrard Lutty and Tailoi Chan-Ling Jennifer Berka-Wilkinson (Monash U...
    View 3 matching archived pages
    This resource is likely to be relevant to your query (score: 0.03)

    This resource is likely to be relevant to your query (score: 0.03)

  2. Website: Voice
    archive.uninews.unimelb.edu.au
    Matching pages:
    View 3 matching archived pages
    This resource is likely to be relevant to your query (score: 0.023)

    This resource is likely to be relevant to your query (score: 0.023)

  3. Website: Australian National Data Service
    demo.ands.org.au
    Matching pages:
    • Research Data Australia - 11/7/2013
    • ... Fletcher Co-Investigator(s): Prof Jennifer Wilkinson-Berka; Prof Mark Gillies; Mr Malcolm Plunkett Total...
    View 2 matching archived pages
    This resource may have relevance to your query (score: 0.018)

    This resource may have relevance to your query (score: 0.018)

  1. SOUTH AUSTRALIA
    Commonwealth of Australia Gazette. Periodic (National : 1977 - 2011) Monday 22 May 1978 p 205

    Government Gazette Notices

    ... 5091, 13 9 76, Barry, Jennifer, 38 Frances Ave, Para Hills 5096, 19 5 76, Barry, Robert, 6 Newman Ave ... , 19 5 76; Bell, Jennifer Margaret, 20 Kelly Rd, Christies Beach 5165, 1 9 76, Bell, Jim Ian, Po Box 3 ... 75581 words
    This resource may only be vaguely related to your query: matching terms may only have been found in the full text contents of the resource (score: 0)

    This resource may only be vaguely related to your query: matching terms may only have been found in the full text contents of the resource (score: 0)

  2. QUEENSLAND
    Commonwealth of Australia Gazette. Periodic (National : 1977 - 2011) Wednesday 25 October 1978 p 276

    Government Gazette Notices

    ... , 9 11 77, Bishop, Harry Munroe, 110 Newnham Rd, Mansfield 4122, 31 1 78, Bishop, Jennifer Chnsanthi ... , Jennifer Anne, 1/7 Hamilton St, Melton Hill 4810, 28 7 77 Carleton, John Harry, 1/7 Hamilton St, Townsville ... 39015 words
    This resource may only be vaguely related to your query: matching terms may only have been found in the full text contents of the resource (score: 0)

    This resource may only be vaguely related to your query: matching terms may only have been found in the full text contents of the resource (score: 0)

  3. CORPORATIONS LAW Subsection 572(2) [coming soon]
    Commonwealth of Australia Gazette. Periodic (National : 1977 - 2011) Friday 8 November 1991 p 2

    Government Gazette Notices

    Extract: CORPORATIONS LAW Subsection 572(2) Notice is hereby given that at the end of three months from the date hereof, the registration of the companies mentioned ... 499711 words
    This resource may only be vaguely related to your query: matching terms may only have been found in the full text contents of the resource (score: 0)

    This resource may only be vaguely related to your query: matching terms may only have been found in the full text contents of the resource (score: 0)